Exxon Debates Abandoning Some Oil, Gas Projects 
 

Members of the company's remade board of directors are questioning several major investments as the company reconsiders its investment strategy in a fast-changing energy landscape.

 
Biogen's New Alzheimer's Drug Meets Slow Rollout 
 

The drugmaker's revenue from the drug, Aduhelm, was $300,000 in the first full quarter since its approval, a figure well below analyst expectations. Sales could be minimal through the end of the year, the company said.

 
China Evergrande Calls Off Plans to Sell Key Unit for $2.6 Billion 
 

The move is a major setback in the real-estate giant's attempts to ease its liquidity crunch.

 
Facebook's Zuckerberg Named in Suit by Washington, D.C., Attorney General 
 

The district's attorney general is seeking to hold Mark Zuckerberg personally liable in a lawsuit stemming from the 2018 Cambridge Analytica personal-data scandal.

 
In-N-Out Burger in San Francisco Closed for Violating City Vaccine Policy 
 

A location of the burger restaurant was shut down for failing to check customers' vaccination status.

 
Blackstone Buying Majority Stake in  Spanx 
 

The deal values Spanx at $1.2 billion. Spanx founder Sara Blakely will maintain a significant stake in the company and continue to oversee operations.

 
Verizon's Earnings Topped Estimates. Its Stock Is Rising. 
 

The telecom giant showed improving subscriber growth numbers for a second quarter, as well as progress in moving customers to more expensive plans in the 5G era.

 
Nestlé Sales Buoyed by Coffee, Pet Food 
 

The Swiss company's upbeat quarter provides an early sign that consumer habits acquired during the pandemic, such as drinking more and better quality coffee at home, could continue to benefit it, despite the ongoing challenges of rising input costs and supply-chain snags.

 
Micron to Expand Chip Production With $150 Billion in Capital Spending 
 

Chief Executive Sanjay Mehrotra says the Boise, Idaho, memory-chip maker is seeking clarity on U.S. financial incentives for the coming decade.

 
Novavax Shares Plunge on Report of Covid-19 Vaccine Manufacturing Problems 
 

A report in Politico said the pharmaceutical company was having difficulties manufacturing a Covid-19 vaccine that met regulators' quality standards.

(END) Dow Jones Newswires

October 20, 2021 13:15 ET (17:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.